Market Closed -
Toronto S.E.
04:00:00 2024-06-07 pm EDT
|
5-day change
|
1st Jan Change
|
12.75
CAD
|
-0.93%
|
|
+2.25%
|
+8.79%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
2,975
|
2,393
|
2,755
|
1,994
|
2,819
|
3,089
|
-
|
Enterprise Value (EV)
1 |
2,975
|
2,393
|
2,755
|
1,994
|
2,819
|
3,089
|
3,089
|
P/E ratio
|
2,837
x
|
164
x
|
263
x
|
40.5
x
|
22.1
x
|
638
x
|
116
x
|
Yield
|
4.3%
|
5.45%
|
5.18%
|
-
|
5.22%
|
4.78%
|
4.82%
|
Capitalization / Revenue
|
3.25
x
|
2.58
x
|
3.04
x
|
2.82
x
|
3.82
x
|
3.38
x
|
3.22
x
|
EV / Revenue
|
3.25
x
|
2.58
x
|
3.04
x
|
2.82
x
|
3.82
x
|
3.38
x
|
3.22
x
|
EV / EBITDA
|
10.6
x
|
8.54
x
|
10.3
x
|
7
x
|
12.6
x
|
10.6
x
|
9.55
x
|
EV / FCF
|
-28.2
x
|
20.4
x
|
-
|
75.7
x
|
-
|
-163
x
|
-
|
FCF Yield
|
-3.54%
|
4.9%
|
-
|
1.32%
|
-
|
-0.62%
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
214,034
|
213,825
|
233,072
|
236,272
|
240,555
|
242,258
|
-
|
Reference price
2 |
13.90
|
11.19
|
11.82
|
8.440
|
11.72
|
12.75
|
12.75
|
Announcement Date
|
2/27/20
|
3/4/21
|
2/24/22
|
3/2/23
|
3/7/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
915.3
|
928.6
|
906.5
|
708
|
738.6
|
912.9
|
958
|
EBITDA
1 |
280.6
|
280
|
267.4
|
284.8
|
223
|
292.1
|
323.4
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
1.067
|
14.88
|
10.13
|
49.53
|
128.3
|
6
|
26
|
Net margin
|
0.12%
|
1.6%
|
1.12%
|
7%
|
17.37%
|
0.66%
|
2.71%
|
EPS
2 |
0.004900
|
0.0682
|
0.0450
|
0.2086
|
0.5307
|
0.0200
|
0.1100
|
Free Cash Flow
1 |
-105.3
|
117.3
|
-
|
26.35
|
-
|
-19
|
-
|
FCF margin
|
-11.51%
|
12.64%
|
-
|
3.72%
|
-
|
-2.08%
|
-
|
FCF Conversion (EBITDA)
|
-
|
41.91%
|
-
|
9.25%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
788.67%
|
-
|
53.19%
|
-
|
-
|
-
|
Dividend per Share
2 |
0.5980
|
0.6100
|
0.6120
|
-
|
0.6120
|
0.6100
|
0.6150
|
Announcement Date
|
2/27/20
|
3/4/21
|
2/24/22
|
3/2/23
|
3/7/24
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
227.3
|
169.9
|
175.9
|
180.5
|
181.7
|
178.3
|
180.8
|
186
|
196.6
|
235.6
|
236.2
|
234.4
|
EBITDA
1 |
-
|
-
|
-
|
60.25
|
-
|
-
|
-
|
-
|
-
|
75.55
|
80
|
78.1
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.1530
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.1500
|
0.1500
|
0.1500
|
Announcement Date
|
2/24/22
|
5/5/22
|
8/11/22
|
11/9/22
|
3/2/23
|
5/4/23
|
8/10/23
|
11/9/23
|
5/9/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-105
|
117
|
-
|
26.3
|
-
|
-19
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/27/20
|
3/4/21
|
2/24/22
|
3/2/23
|
3/7/24
|
-
|
-
|
Last Close Price
12.75
CAD Average target price
15.1
CAD Spread / Average Target +18.43% Consensus |
1st Jan change
|
Capi.
|
---|
| +8.79% | 2.25B | | +15.13% | 62.07B | | -0.26% | 20.09B | | -2.58% | 13.58B | | +4.83% | 7.94B | | +15.42% | 3.73B | | +9.37% | 3.22B | | -1.96% | 3.24B | | -8.88% | 2.98B | | +17.44% | 2.85B |
Healthcare REITs
|